Doç. Dr. RABİA LEBRİZ USLU BEŞLİ

Yayın Ağı

Makaleler 88

1. Use of Contrast Agents in Positron Emission Tomography/ Magnetic Resonance Imaging Pozitron Emisyon Tomografisi/Manyetik Rezonans Görüntülemede Kontrast Madde Kullanimi

Toplutaş K. N., Beşli R. L.

Nuclear Medicine Seminars , cilt.10, sa.3, ss.241-248, 2024 (Scopus)

2. Positron Emission Tomography/Magnetic Resonance Imaging in Urological Ürolojik Kanserlerde Pozitron Emisyon Tomografisi/Manyetik Rezonans Görüntüleme

Beşli R. L.

Nuclear Medicine Seminars , cilt.10, sa.3, ss.329-343, 2024 (Scopus)

3. Comparison of Thyroid Uptake Values Measured from 131I Scintigraphy and Uptake Probe in Hyperthyroid Patients.

YEYİN N., Akyol S., Uslu-Beşli L., DEMİR M.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre , cilt.34, sa.1, ss.48-56, 2024 (SCI-Expanded, Scopus)

4. Osteosarcoma metastatic to the thyroid gland: A rare case report Tiroid bezine osteosarkom metastazı: Nadir bir olgu

Soylu S., ÖZTÜRK T., ONUR İ., Uslu L., TEKSÖZ S.

Turkish Journal of Surgery , cilt.40, sa.4, ss.353-356, 2024 (ESCI, Scopus, TRDizin)

5. Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization

Yeyin N., Kesmezacar F. F., Tunçman D., Demir Ö., Uslu-Beşli L., Günay O., et al.

CURRENT RADIOPHARMACEUTICALS , cilt.17, sa.3, ss.276-284, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Cytomorphological and clinical features of follicular variant papillary thyroid carcinoma (with focal insular pattern) metastasis to kidney

Erdogan-Durmus S., Yol C., Uslu-Besli L., Uygun N.

Journal of Cytology , cilt.40, sa.4, ss.214-216, 2023 (SCI-Expanded, Scopus)

7. Dramatic treatment response images of a metastatic lung adenocarcinoma case with Osimertinib treatment on 18F-FDG PET/CT

Ince B., Namazova A., Bodur M., Asa S., Uslu-Besli L., Sager S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)

8. Comparison of 68Ga-PSMA PET/MRI with PET and mpMRI in concise evaluation of primary prostate tumor and its prognostic value in detection of locally advanced prostate cancer

Uslu-Besli L., Bakir B., Urganci N., Gurses G., Ozel-Yildiz S., DEMİRDAĞ Ç., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)

9. 18F-FDG PET/MRI Image of Skin Metastasis of Ovarian Cancer

KİBAR A., ASA S., Beşli R. L., Sağer M. S., SÖNMEZOĞLU K.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.32, sa.2, ss.159-161, 2023 (ESCI, TRDizin)

10. Comparison of Whole-Body Ga-68 DOTA TATE Positron Emission Tomography and Magnetic Resonance Imaging in the Detection of Bone Metastasis of Neuroendocrine Tumor in Simultaneous 3T Positron Emission Tomography/Computed Tomography

ASA S., Kibar A., BESLI L. U., Eryürekli A. E., SAMANCI C., SAĞER M. S., et al.

Cerrahpaşa Medical Journal , cilt.47, sa.1, ss.7-13, 2023 (TRDizin)

11. Bilateral Lymphadenopathy After COVID Vaccine in ¹⁸F-Choline PET/MRI Performed for Hyperparathyroidism

Kibar A., Aghazada F., Asa S., Besli R. L., Sonmezoglu K.

CLINICAL NUCLEAR MEDICINE , cilt.48, sa.3, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Is there a potential biomarker in distinguishing invasive breast carcinomas with elevated Ki-67 levels among 2D-SWE, SMI, and 18F-FDG PET-CT/MRI-derived parameters?: A single-center data

ALADAĞ KURT S., Besli L. U., KAYADİBİ Y., SAMANCI C., NAZARI A., ÖZTÜRK T., et al.

JOURNAL OF CLINICAL ULTRASOUND , cilt.51, sa.1, ss.148-157, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Determination of Embryo/Fetus Doses of Pregnants in Thorax Computed Tomography Scan

Demir M., Isikci N. I.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.38, ss.476-481, 2023 (ESCI, Scopus, TRDizin)

14. Predicting axillary nodal metastasis based on the side of asymmetrical cortical thickening in breast cancer: Evaluation with grayscale and microvascular imaging findings.

Aladag Kurt S., Kayadibi Y., Onur I., Uslu Besli L., Necati Sanli A., Velidedeoglu M.

European journal of radiology , cilt.158, sa.158, ss.110643, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following I-131 therapy

ABUQBEITAH M., DEMİR M., Sager S., ASA S., Isikci N. I., SÖNMEZOĞLU K.

HEALTH AND TECHNOLOGY , cilt.13, sa.1, ss.101-110, 2023 (ESCI, Scopus)

16. Original research patients undergoing multiple F-18-FDG PET/CT scans: frequency, clinical indications, and cumulative dose

ABUQBEITAH M., DEMİR M., Soenmezoglu K., SAYMAN H. B., KABASAKAL L., Sager S., et al.

HEALTH AND TECHNOLOGY , cilt.13, sa.1, ss.89-97, 2023 (ESCI, Scopus)

17. Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance

Asa S., Ozgur E., Uslu-Besli L., Ince B., Sager S., Demirdag C., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.44, sa.1, ss.65-73, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. The analysis of F-18-FDG PET/MRI, electroencephalography, and semiology in patients with gray matter heterotopia: A pilot study

ALİŞ C., ALİS D. C., Besli L. U., KARAARSLAN E., SÖNMEZOĞLU K., ÖZKARA Ç., et al.

ACTA NEUROLOGICA SCANDINAVICA , cilt.146, sa.5, ss.662-670, 2022 (SCI-Expanded, Scopus)

19. Does Previous 177Lu DOTATATE Treatment Effect 90Y Microsphere Treatment in Neuroendocrine Tumor Patients with Liver Metastasis

Aghazada F., Kibar A., Ince B., Uslu-Besli L., SAMANCI C., Bas A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

20. Diagnostic Performance of Hybrid Ga-68 PSMA PET/ MR Compared to PET Alone and Prostate MR Imaging in Primary Prostate Cancer Patients

Uslu-Besli L., Bakir B., Urganci N., Gurses I., Guner E., DEMİRDAĞ Ç., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Evaluation of Tc-99m-MAA SPECT/CT-based dosimetry with Y-90 PET/MR-based dosimetry in Y-90 microsphere treatment

Namazova A., Yeyin N., Besli L. U., SÖNMEZOĞLU K.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

22. Relationship between SUVmax and ADC values of metastatic lymph nodes also ADC values of metastatic and reactive lymph nodes detected by Ga-68 PSMA PET/MR in prostate cancer patients

Aghazada F., Kibar A., Uslu-Besli L., Sager S., SAYMAN H. B., SÖNMEZOĞLU K.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Ga-68 PSMA PET/MRI Imaging In Detecting Local Residue Or Recurrence In Patients With Prostate Cancer

Ince B., Besli L. U., Bakir B., Eken S., Sager S., DEMİRDAĞ Ç., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. The Effect Of High-Dose Radioiodine Therapy On Lacrimal Gland Function In Patients With Differentiated Thyroid Cancer

Namazova A., Sahin K., Guneren C., Ince B., Aghazada F., Sager S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Comparison of PET and MRI sequences separately in the detection of bone metastases in patients with neuroendocrine tumor who underwent 3T Ga-68 DOTA TATE PET/MR

Kibar A., Asa S., Uslu-Besli L., Eryurekli A., SAMANCI C., Sager S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

26. Relationship between serum sialic acid levels and prolidase activity with airflow obstruction in patients with COPD

UYSAL P., Teksoz D., Aksan H., DURMUŞ S., Uslu-Besli L., ÇUHADAROĞLU Ç., et al.

MEDICINE , cilt.101, sa.11, 2022 (SCI-Expanded, Scopus)

27. F-18-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Appearance of Gastrointestinal Behcet's Disease

İnce B., Kibar A., Asa S., Uslu Beşli R. L., Sağer M. S., Eşkazan A. E., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.31, sa.1, ss.57-59, 2022 (ESCI, TRDizin)

28. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT

Asa S., Sönmezoğlu K., Uslu-Besli L., Şahin O. E., Karayel E., Pehlivanoglu H., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.35, ss.900-915, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients

Sager G., Akgun E., Abuqbeitah M., Uslu L., ASA S., Akgun M. Y., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.206, 2021 (SCI-Expanded, Scopus)

30. Active Giant Cell Vasculitis Diagnosis with ⁶⁸Ga PSMA PET/CT Imaging.

Sağer M. S., Bilgiç S., Uslu L., Asa S., Sağer G., Sönmezoğlu K.

Molecular imaging and radionuclide therapy , cilt.30, sa.1, ss.57-59, 2021 (Scopus, TRDizin)

31. Comparison of ¹⁸F-FDG PET/CT and DW-MRI in assessment of neoadjuvant radiochemotherapy response in locally advanced rectal cancer patients.

Uslu-Beşli L., Mermut Ö., Yardimci A. H., Gündoğan C., Gürsu R. U., Çermik T. F.

Revista espanola de medicina nuclear e imagen molecular , cilt.40, ss.19-29, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE

Erhamamcı S., Sager S., Asa S., Uslu L., Akgun E., Sonmezoglu K.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.39, sa.6, ss.383-386, 2020 (SCI-Expanded, Scopus)

33. The role of Ga-68-DOTATATE PET/CT and F-18-FDG PET/CT in the follow-up of patients with medullary thyroid cancer

Sahin O. E., USLU BEŞLİ R. L., Asa S., Sager S., Sonmezoglu K.

HELLENIC JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.3, ss.321-329, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. The role of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in the follow-up of patients with medullary thyroid cancer

Şahin O. E., Uslu-Beşli L., Asa S., Sağer S., Sönmezoğlu K.

Hellenic Journal of Nuclear Medicine , cilt.23, sa.3, ss.321-329, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in Conventional Imaging

Uslu-Beşli L., Sonmezoglu K., Teksoz S., Akgun E., Karayel E., Pehlivanoglu H., et al.

KOREAN JOURNAL OF RADIOLOGY , cilt.21, sa.2, ss.236-247, 2020 (SCI-Expanded, Scopus)

36. Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology in Terms of Anatomic Correlation of FDG-positive Lesions.

Uslu-Besli L., Kapucu L. O. A., KARADENİZ C., AKDEMİR Ü. Ö., PINARLI F. G., Aydos U., et al.

Journal of pediatric hematology/oncology , cilt.41, sa.7, ss.542-550, 2019 (SCI-Expanded, Scopus)

37. Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study

Uslu-Besli L., Bakir B., Asa S., Guner E., Demirdag C., Sahin O. E., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.28, sa.3, ss.104-111, 2019 (ESCI, Scopus, TRDizin)

38. Comparison between planar, SPECT and SPECT/computed tomography systems in 99mTc- nanocolloid sentinel lymph node imaging: phantom design and clinical investigations. Erratum.

IŞIKCI N., ABUQBEITAH M., GUNAY O., Yeyin N., USLU-BESLI L., SAGER S., et al.

Nuclear medicine communications , cilt.40, ss.973, 2019 (SCI-Expanded, Scopus)

39. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

Sager S., Akgun E., USLU-BESLI L., Asa S., Akovali B., SAHIN O., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.5, ss.461-468, 2019 (SCI-Expanded, Scopus)

40. Prostat kanseri olgularında Ga-68 PSMA PET görüntülemenin multiparametrik MR görüntülemeye katkısı

Bakır B., Onay A., Çolak E., Uslu Beşli R. L.

Türkiye Klinikleri , cilt.1, ss.27-33, 2019 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

41. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients

USLU-BESLI L., Sager S., Akgun E., Asa S., Sahin O. E., Demirdag C., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.1, ss.301-310, 2019 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

42. Prostat Kanserinde İndeks Lezyona Yönelik Olarak PET/BT ve PET/MR’ın Kıyaslanması

Şahin O. E., Uslu Beşli R. L.

Türkiye Klinikleri , cilt.1, ss.14-19, 2019 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

43. Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy

Abuqbeitah M., Demir M., Cavdar I., Tanyildizi H., Yeyin N., Uslu-Besli L., et al.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.57, sa.4, ss.395-404, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Abuqbeitah M., Demir M., Kabasakal L., Cavdar I., Uslu-Besli L., Yeyin N., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.11, ss.969-975, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Calculation of Embryo/Fetus Dose in Pregnant Thyroid Patients Who Have Accidentally Received Radioiodine

DEMİR M., ÇAVDAR İ., YEYİN N., Abuqubetah M., USLU BEŞLİ R. L., İpek N., et al.

Okmeydanı Tıp Dergisi , cilt.1, ss.1-4, 2018 (SCI-Expanded, Scopus, TRDizin)

46. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography

Sager S., Vatankulu B., Sahin O. E., Cinaral F., Uslu L., Baran A., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.5, ss.989-993, 2018 (SCI-Expanded, Scopus)

47. Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients

SAGER S., HATIPOGLU E., GUNES B., ASA S., Uslu L., SÖNMEZOGLU K.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , cilt.9, sa.6, ss.177-183, 2018 (SCI-Expanded, Scopus)

48. Blood clearance and occupational exposure for Lu-177-DOTATATE compared to Lu-177-PSMA radionuclide therapy

Abuqbeitah M., Demir M., Uslu-Besli L., Yeyin N., Sonmezoglu K.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.57, sa.1, ss.55-61, 2018 (SCI-Expanded, Scopus)

49. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation

Uslu-Besli L., Kabasakal L., Sager S., Cicik E., Asa S., Sonmezoglu K.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.38, sa.11, ss.964-970, 2017 (SCI-Expanded, Scopus)

50. Comparison of Therapy Response Between PERCIST and RECIST Criteria After Yttrium-90 Therapy in HCC Patients

Sager S., Akgun E., Uslu L., Asa S., Sahin O. E., Akovali B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

51. Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology: Gazi University Pediatric PET/MRI Experience

Kapucu L. O. A., Besli L. U., Akdemir U. O., Aydos U., Ozcelik M., Pinarli F. G., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

52. Comparison of F-18 Choline PET/CT with Tc-99m MIBI and USG for Detection of Parathyroid Adenomas in Patients with Elevated Parathyroid Hormone Levels: Preliminary Results

Uslu-Beli L., Sonmezoglu K., Akgun E. K., Teksoz S., Karayel E., Pehlivanoglu H., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2017 (SCI-Expanded, Scopus)

53. Effects of altered thyroid states on oxidative stress parameters in rats.

OKTAY S., Uslu L., EMEKLI N.

Journal of basic and clinical physiology and pharmacology , cilt.28, ss.159-165, 2017 (Scopus)

54. <sup>18</sup>F-FDG PET/CT in initial staging and treatment response evaluation in a patient with thymoma.

Uslu-Beşli L., Akın Y., Çermik T.

Revista espanola de medicina nuclear e imagen molecular , cilt.36, ss.339-340, 2017 (SCI-Expanded, Scopus)

55. The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats

Terzioglu D., Uslu L., Simsek G., Atukeren P., Erman H., Gelisgen R., et al.

JOURNAL OF INVESTIGATIVE SURGERY , cilt.30, sa.6, ss.376-382, 2017 (SCI-Expanded, Scopus)

56. Toraks malignitelerinde PET/MR görüntüleme

Uslu Beşli R. L., Sağer M. S.

Türkiye Klinikleri , cilt.1, ss.208-214, 2017 (Hakemsiz Dergi)

57. Karaciğer, safra yolları, safra kesesi ve pankreas malignitelerinde PET/MR görüntüleme

Asa S., Uslu Beşli R. L.

Türkiye Klinikleri , cilt.1, ss.222-227, 2017 (Hakemsiz Dergi)

58. Pediatrik görüntülemede pozitron emisyon tomografi/manyetik rezonans görüntüleme uygulamaları

Uslu Beşli R. L., Akdemir Ü. Ö., Atay L. Ö.

Nuclear Medicine Seminars , cilt.1, ss.59-65, 2017 (Hakemsiz Dergi)

59. Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy

USLU BEŞLİ R. L., Uslu İ.

Bagcilar Medical Bulletin , cilt.1, sa.1, ss.30-32, 2016 (Hakemli Dergi)

60. Incidental Detection of Follicular Thyroid Carcinoma in Ga-68-PSMA PET/CT Imaging

Sager S., Vatankulu B., Uslu L., Sonmezoglu K.

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY , cilt.44, sa.3, ss.199-200, 2016 (ESCI, Scopus)

61. Depiction of ventriculoperitoneal shunt obstruction with single-photon emission computed tomography/computed tomography.

AKSOY S., VATANKULU B., Uslu L., HALAC M.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India , cilt.31, ss.246-7, 2016 (ESCI, Scopus)

62. Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: A case report

Uslu-Besli L., Demir M., Yeyin N., Cavdar I.

IRANIAN JOURNAL OF NUCLEAR MEDICINE , cilt.24, sa.2, ss.144-146, 2016 (ESCI, Scopus)

63. Evaluation of radiation safety in Lu-177-PSMA therapy and development of outpatient treatment protocol

DEMIR M., ABUQBEITAH M., Uslu-Beşli L., YıLDıRıM Ö., YEYIN N., CAVDAR I., et al.

JOURNAL OF RADIOLOGICAL PROTECTION , cilt.36, sa.2, ss.269-278, 2016 (SCI-Expanded, Scopus)

64. Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure

Yeyin N., Cavdar I., Uslu L., Abuqbeitah M., Demir M.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.3, ss.283-287, 2016 (SCI-Expanded, Scopus)

65. PET ile Onkolojide Çocukluk Çağı Tümörleri

Uslu Beşli R. L.

Türkiye Klinikleri , cilt.1, ss.122-128, 2016 (Hakemsiz Dergi)

66. PET ile Onkolojide Tedaviye Yanıtın Değerlendirilmesi: Çocukluk Çağı Tümörleri

USLU BEŞLİ R. L.

Türkiye Klinikleri J Nucl Med-Special Topics , cilt.2, sa.1, ss.122-128, 2016 (Hakemsiz Dergi)

67. Radyoaktif tedavi sonrasi tedaviye yanitin değerlendirilmesi: I-131 tedavisi sonrasi tiroid hastalıkları

Özgüven S., Uslu Beşli R. L., Uslu İ.

Türkiye Klinikleri , cilt.1, ss.203-207, 2016 (Hakemsiz Dergi)

68. Tc-99m MIBI Paratiroid Sintigrafisinde Tek Foton Emisyon Tomografisi/Bilgisayarlı Tomografi Kullanımının Klinik Önemi

Erdil T. Y., USLU BEŞLİ R. L.

Nuclear Medicine Seminars , cilt.1, sa.1, ss.49-56, 2016 (Hakemsiz Dergi)

69. Radyoaktif Tedavi Sonrası Tedaviye Yanıtın Değerlendirilmesi: I-131 Tedavisi Sonrası

Özgüven S., USLU BEŞLİ R. L., Uslu İ.

Türkiye Klinikleri J Nucl Med-Special Topics , cilt.2, sa.1, ss.203-207, 2016 (Hakemsiz Dergi)

70. Tc-99m MIBI paratiroid sintigrafisinde tek foton emisyon tomografisi/bilgisayarlı tomografi kullanımının klinik önemi

Erdil T. Y., Uslu Beşli R. L.

Nükleer Tıp Seminerleri , cilt.1, ss.49-56, 2016 (Hakemsiz Dergi)

71. Determining and Managing Fetal Radiation Dose from Diagnostic Radiology Procedures in Turkey

Ozbayrak M., Cavdar I., Seven M., Uslu L., Yeyin N., Tanyildizi H., et al.

KOREAN JOURNAL OF RADIOLOGY , cilt.16, sa.6, ss.1276-1282, 2015 (SCI-Expanded, Scopus)

72. Bilateral breast uptake of radioiodine in a male patient with gynecomastia: A case report.

Uslu L., OZBAYRAK M., VATANKULU B., SÖNMEZOGLU K.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India , cilt.30, ss.345-6, 2015 (ESCI, Scopus)

73. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.

Uslu L., DONIG J., LINK M., ROSENBERG J., QUON A., DALDRUP-LINK H.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , cilt.56, ss.274-86, 2015 (SCI-Expanded, Scopus)

74. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.

YILMAZ S., ALIYEV A., EKMEKCIOGLU O., OZHAN M., Uslu L., VATANKULU B., et al.

Nuklearmedizin. Nuclear medicine , cilt.54, ss.262-71, 2015 (SCI-Expanded, Scopus)

75. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level

Asa S., AKSOY S. Y., Vatankulu B., Aliyev A., Uslu L., OZHAN M., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.28, sa.10, ss.970-979, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers

Sager S., Asa S., Yilmaz M., Uslu L., Vatankulu B., Halac M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.4, ss.922-926, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.

KLENK C., GAWANDE R., Uslu L., KHURANA A., QIU D., QUON A., et al.

The Lancet. Oncology , cilt.15, ss.275-85, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT

Uslu L., Asa S., Sager S., Halac M.

NUKLEARMEDIZIN-NUCLEAR MEDICINE , cilt.53, sa.2, 2014 (SCI-Expanded, Scopus)

79. Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with F-18-FDG-PET and MIBI images

Sager S., Kabasakal L., Ocak M., Maecke H., Uslu L., Halac M., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.34, sa.12, ss.1190-1195, 2013 (SCI-Expanded, Scopus)

80. Preoperative and Postoperative (18)FDG PET/CT and Bone Scintigraphy Images in a Patient With Parathyroid Adenoma

Uslu L., CALIŞKAN A., SAGER S., TEKSÖZ S., HALAC M.

CLINICAL NUCLEAR MEDICINE , cilt.38, sa.6, ss.456-458, 2013 (SCI-Expanded, Scopus)

81. Comparison of Tc-99m-HYNIC-TOC and HYNIC-TATE Octreotide Scintigraphy With FDG PET and Tc-99m-MIBI in Local Recurrent or Distant Metastatic Thyroid Cancers

Sager S., Kabasakal L., Halac M., Maecke H., Uslu L., Onsel C., et al.

CLINICAL NUCLEAR MEDICINE , cilt.38, sa.5, ss.321-325, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

82. Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with F-18-FDG PET/CT

Uslu L., SEN F., SAGER S., HALAC M.

NUKLEARMEDIZIN-NUCLEAR MEDICINE , cilt.52, sa.5, 2013 (SCI-Expanded, Scopus)

83. Comparison of I-123 MIBG scintigraphy with somatostatin receptor scintigraphy using Tc-99m HYNIC TATE in neuroblastoma patients

Uslu L., Kabasakal L., Ocak M., Tuysuz G., Celkan T., Apak H., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

84. Increased orbital rectus muscle F-18 FDG uptake and its correlation with muscle thickness in Graves' patients

Uslu L., Kabasakal L., Cicik E., Halac M., Kanmaz B.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

85. Comparison of the aggressiveness of papillary thyroid microcarcinomas (<= 10 mm) with papillary thyroid carcinomas larger than 11 mm and less than 20 mm in diameter

Caliskan F. A., Uslu R. L., Sager S., Onsel C., Sayman H. B., Kabasakal L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

86. Radioembolization Using YTTRIUM-90 Microspheres for Advanced Primary and Metastatic Liver Malignancies

Uslu L., Arslan E., Ozhan M., Nisli S., Sager S., Kabasakal L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

87. Unilateral thalamic hypometabolism on FDG brain PET in patient with temporal lobe epilepsy.

SAGER S., ASA S., Uslu L., HALAC M.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India , cilt.26, ss.94-5, 2011 (SCI-Expanded, Scopus)

88. Characteristics of primary cutaneous B-cell lymphomas: Clinicopathologic features, immunophenotypic profile and prognostic factors

Uslu L., Demirkesen C., OGUZ O., ONSUN N., TUZUNER N.

VIRCHOWS ARCHIV , cilt.451, sa.2, ss.455, 2007 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 39

1. Enflamatuar Diz Eklemi Problemli Hastalarda Lutesyum-177 İle Rad- yasyon Sinovektomi (Radyosino- vektomi) Uygulaması - Lu-177 Maa İle İlk Deneyimler

Özşahin M. K., Özer M., Davulcu C. D., Sağlam K., Sağer M. S., Bilgiç S., et al.

33. Ulusal Türk Ortopedi ve Travmatoloji Kongresi, Antalya, Türkiye, 5 - 10 Kasım 2024, ss.137, (Özet Bildiri)

2. Tuberculosis Lymphadenitis Mimicking Malignancy

Güneren C., Uslu Beşli R. L., Sayman H. B.

EANM, Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, ss.880-881, (Özet Bildiri)

3. Evaluation of the efficacy of the Lu-177 DOTATATE Treatment in Inoperable/Metastatic Paraganglioma and Malignant Pheochromocytoma

Guneren C., Besli L. U., Sahin K., Sahin O. E., Yıldız Özbek S., Kabasakal L., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

4. The Role of ¹⁸F-Tetrafluoroborate Imaging in the Follow-up of Patients with Differentiated Thyroid Cancer

Saglam K., Sahin O. E., Bodur M. T., KARAYEL E., Pehlivanoglu H., Aygun A., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, (Özet Bildiri)

5. Comparison of Ga-68 DOTATATE PET and Ga-68 PSMA PET in Radioactive Iodine Refractory Thyroid Cancer

Kibar A., Sager S., Sahin K., Biyikoglu S. E., Bodur M. T., Saglam K., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

6. İnoperabl/Metastatik Paraganglioma Ve Malign Feokromasitoma Tanılı Hastalarda LU-177 DOTATATE Tedavi Yanıtı

Güneren C., Uslu Beşli R. L., Şahin K., Şahin O. E., Kabasakal L., Sayman H. B.

36. Ulusal Nükleer Tıp Kongresi, Girne, Kıbrıs (Kktc), 8 - 12 Mayıs 2024, (Yayınlanmadı)

7. Evaluation of Liver Lesions with Diffusion Weighted Imaging PET/MRI in Transarterial Radioembolization Treatment Patients

Kibar A., Aghazada F., Uslu-Besli L., Sahin O. E., Asa S., Sager S., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Eylül 2023, (Özet Bildiri)

8. FDG-PET/BT'de Prostat Bezinde İzlenen İnsidental Tutulumun Klinik Önemi

Güneren C., Şahin K., Kibar A., Sağer M. S., Uslu Beşli R. L., Asa S., et al.

35. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 26 - 30 Nisan 2023, (Yayınlanmadı)

9. The contribution of PET/MR in benign malignant nodule separation in thyroid incidentalomas detected in FDG PET/ CT imaging

Nazarı A., Sağer M. S., Bilgiç S., Toplutaş K. N., Beytur M. F., Uslu Beşli R. L., et al.

Annual Congress of the European Association of Nuclear Medicine, Barcelona, İspanya, 15 - 19 Ekim 2022, ss.200, (Özet Bildiri)

10. F-18 DOPA PET imaging in hyperinsulinemic hypoglicemia

Toplutas K., Uslu-Besli L., Asa S., Sager S., Karayel E., Pehlivanoglu H., et al.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri)

11. The Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up

Toplutas K., Sager S., Besli R. L., Asa S., Khosroshahi S., Sayman H. B., et al.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Survival Analysis of Advanced HCC Treated with Yttrium-90 Radioembolization: A 10-year single-center experience

Bilgic S., Sager M. S., Akovali B., Sahin O. E., Kaymak E., Besli R. L., et al.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)

13. Comparison Of Ga-68 PSMA PET/MRI With Textural Analysis Data In Transitional Zone Prostate Tumors: Preliminary Results Of An On-Going Study

Uslu L. L., Tuncer S., Bakir B., Yildiz S. O., Demirdag C., Guner E., et al.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)

14. Value Of Hybrid F-18 FDG PET/MRI In BIRADS 4 And 5 Breast Lesions: Preliminary Results Of An On-Going Study

Uslu L. L., Yilmaz R., Velidedeoglu M., Sahin O. E., Akgun E., Sager S., et al.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)

15. Comparison of Ga68 PSMA PET/CT and PET/MRI with biparametric prostate MRI in terms of location of prostate tumour

USLU BEŞLİ R. L.

XVI. Balkan Congress of Radiology, İzmir, Türkiye, 4 - 06 Ekim 2018, ss.59, (Özet Bildiri)

16. Comparison of PET and DWI images in the detection of bone metastasis of prostate cancer in Ga-68 PSMA PET / MR

Asa S., Besli R. L., Ozgur E., Khosroshahi S., Bakir B., Demirdag C., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Comparison of Ga-68 PSMA PET/CT and Ga-68 PSMA PET/MRI with biparametric prostate MRI in terms of location and extension of primary prostate gland tumour

Besli L. U., Asa S., Bakir B., Sayman H. B., Sager S., Khosroshahi B. R., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

18. Comparison of F-18 FDG PET/CT and DWI-MRI in early assessment of neoadjuvant radiochemotherapy response in locally advanced rectal cancer patients

Uslu-Besli L., Mermut O., Yardimci H., Gundogan C., Gursu R., Cermik T.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

19. A new device (COTI) for thyroid uptake measurement and prospective dosimetry oriented therapy

Abuqbeitah M., DEMİR M., Yeyin N., Gray D., Sager S., Uslu-Besli L., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

20. Contribution of 68Ga-PSMA-11 PET/CT imaging in Gleason Score 3+3=6 Prostate Cancer

Sahin O. E., Gilgic S., Sager S., Akovali B., Akgun E., Uslu-Besli L., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, (Özet Bildiri)

21. The feasibility of relying on dose calculation for more successive therapy in Graves and Toxic adenoma guided by one year follow up

Abuqbeitah M., Sager S., Yeyin N., Uslu-Besli L., DEMİR M., Sonmezoglu K.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, sa.1, (Özet Bildiri)

22. The value of Ga-68 DOTA-TATE PET/CT scanning in the Assessment of Vandetanib Treatment Response in Advanced Medullary Thyroid Cancer

Sahin O. E., Asa S., Khosroshahi S. R., Uslu-Besli L., Uslu I., Sonmezoglu K.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Is low-dose radioiodine treatment sufficient for a successful remnant tissue ablation in low-moderate risk thyroid cancer patients?

Khosroshahi S. R., Sahin O. E., Besli L. U., Sager S., Asa S., Akgun E., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Correlation of SUVmax and ADC values detected by Ga-68 PSMA PET/MRI in primary prostate lesions and their significance in lymph node metastasis

Uslu-Besli L., Asa S., Bakir B., Sayman H. B., Sager S., Khosroshahi B. R., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

25. Does adding Hounsfield unit measurement on standardized uptake value helpful in differentiating thyroid nodules?

USLU BEŞLİ R. L.

Uluslararası Bilimsel Araştırmalar Kongresi, Nevşehir, Türkiye, 9 - 12 Eylül 2018, ss.128, (Özet Bildiri)

26. Du¨s¸u¨k Doz radyoaktif ı-131 Tedavisi Ablasyonda Beklentileri kars¸ılıyor mu?

RAZAVIKHOSROSHAHI S., ŞAHİN O. E., SAĞER M. S., ASA S., USLU BEŞLİ R. L., AKGÜN E., et al.

30. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 12 - 14 Nisan 2018, ss.21, (Özet Bildiri)

27. prostat kanserli Hastalarda prostat Lezyonlarının Degˆerlendirilmesinde ga-68 pSMA peT/BT ile ga-68 pSMA peT/Mr ve Biparametrik Mr go¨ru¨ntu¨lemenin kars¸ılas¸tırılması

USLU BEŞLİ R. L., ASA S., BAKIR B., SAYMAN H. B., SÖNMEZOĞLU K.

30. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 12 - 14 Nisan 2018, ss.5, (Özet Bildiri) Sürdürülebilir Kalkınma

28. Comparison of F-19 Choline PET/CT with Tc-99m MIBI and USG for detection of parathyroid adenomas in patients with elevated parathyroid hormone levels: Preliminary results

Uslu Beşli R. L., Sönmezoğlu K., Akgün E., Teksöz S., Karayel E., Pehlivanoğlu H., et al.

Annual Congress of the European Association of Nuclear Medicine, Vienna, Avusturya, 21 - 25 Ekim 2017, cilt.44, ss.153, (Özet Bildiri)

29. Radiation exposure in 177Lu-PSMA & the possibility of applying outpatient treatment rules

Abuqbeitah M., DEMİR M., Yeyin N., Uslu L., Vatankulu B., Kabasakal L., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

30. 68Ga-PSMA HBED-CC PET/CT imaging may be useful in detection of differentiated thyroid cancer: a comparative study with 68Ga-DOTA-TATE PET/CT and 18F-FDG PET/CT imaging

Vatankulu B., Akgun E., Ocak M., Demirci E., Uslu L., Sager S., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri) Sürdürülebilir Kalkınma

31. The value of thyroglobulin measurement in fine needle aspirates from cervical lymph nodes of thyroid cancer patients

Sayman H. B., Yilmaz S., Nisli S., Ozhan M., Uslu L., Akyel R., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri) Sürdürülebilir Kalkınma